Abiopharma

武田薬品、原発性免疫不全症（PID）を対象としたTAK-881の主要第2/3相臨床試験で良好なトップライン結果を発表

Director Walsh Elizabeth L. 🟢 acquired 4.6K shares of Carter Bankshares, Inc. (CARE) at $26.20 Transaction Date: May 06, 2026 | Filing ID: 000008

VanEck Space ETF (WARP) was added to the exchange traded list on NASDAQ

(19% Negative) HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) Reports Q2 2026 Financial Results

21Shares Canton Network ETF (TCAN) was added to the exchange traded list on NASDAQ

Suja Life, Inc. - Class A Common Stock (SUJA) was added to the exchange traded list on NASDAQ

(99% Neutral) BLACKROCK TCP CAPITAL CORP. (TCPC) Announces Business Combination

(75% Positive) FIRST UNITED CORP/MD/ (FUNC) Reports Q2 2026 Financial Results

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest/Changes in Interest of Director/Chief Executive Officer

(30% Negative) EDGEWISE THERAPEUTICS, INC. (EWTX) Reports Q2 2026 Financial Results

LeonaBio Enhances Board of Directors with Appointments of Fred Callori, J.D., Natalie Holles and Peter B. Silverman, J.D.

Volato Group Shareholders Approve Merger with M2i Global

Alcoa Corporation Declares Quarterly Cash Dividend

Meeting results from 7.5.26 – reappointments, management agreement with Fox

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001193125-26-211121 <b>Size:</b> 695 KB